Nanalysis Reports Third Quarter 2025 Financial Performance Amid Market Challenges Nanalysis Scientific Corp. publicly shares its financial outcomes for the third quarter of 2025, detailing challenges and operational improvements in various segments.

Nanalysis Reports Third Quarter 2025 Financial Performance Amid Market Challenges #Canada #Calgary #Benchtop_NMR #Nanalysis_Scientific #NMR_Technology

Nanalysis Introduces Benchmarked NMR Assay for Quality Control in Pharmaceuticals Nanalysis Scientific leads the way as they launch the first regulatory-approved assay for pharmaceutical quality control using benchtop NMR technology.

Nanalysis Introduces Benchmarked NMR Assay for Quality Control in Pharmaceuticals #Canada #Calgary #Nanalysis #Benchtop_NMR #Hydroxypropyl_Betadex

Nanalysis Teams Up with USP to Highlight Benchtop NMR Benefits for Pharma Quality Control Nanalysis Scientific Corp. collaborates with USP to show the effectiveness of benchtop NMR in pharmaceutical quality control. This breakthrough promises enhanced efficiency and reliability.

Nanalysis Teams Up with USP to Highlight Benchtop NMR Benefits for Pharma Quality Control #Canada #Calgary #Nanalysis #USP #Benchtop_NMR